Xenazine
NDC 67386-422, tetrabenazine, tablet, from Lundbeck Pharmaceuticals LLC.
- Product NDC
- 67386-422
- Status
- Listed
- Labeler
- Lundbeck Pharmaceuticals LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021894
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67386-422 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TETRABENAZINE25 mg/1
Pharmacologic classes
Vesicular Monoamine Transporter 2 Inhibitor [EPC]; Vesicular Monoamine Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67386-422-01 | 67386042201 | 112 TABLET in 1 BOTTLE (67386-422-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ac768bab-8afa-4446-bc7f-caeeffec0cda
Use it
Look up 67386-422 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67386-422 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67386-422. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.